Kaitlyn D’Onofrio

DocwireNews

A study examined how publications are reporting health&#8208;related quality of life (HRQOL) in clinical trials supported by the <a href="https://www.docwirenews.com/docwire-pick/home-page-picks/study-mutant-genes-severe-breast-cancer/">National Cancer Institute (NCI)</a>.&ldquo;The importance of capturing and reporting health&#8208;related quality of life (HRQOL) in clinical trials has been increasingly recognized in the oncology field. As a result, the National Cancer Institute (NCI) began to provide support for correlative HRQOL studies in cancer treatment trials. The current study was conducted to assess the publication rate of HRQOL correlative studies in NCI&#8208;supported treatment trials and to identify potential factors positively or negatively associated with publication rates,&rdquo; the study authors wrote.This was a retrospective review of <a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/five-facts-about-oncologist-dr-hahn-tapped-by-trump-to-head-fda/">NCI databases</a> in order to locate cancer treatment trials that received funding from the NCI to assess HRQOL and determine the prevalence of HRQOL studies that have been completed and published in a peer-reviewed journal.Final analysis included 108 trials, of which 58 (54%) had a parent trial publication. Of those with a parent trial publication, 36 (62%) had a published HRQOL result (independent publication, n=20; included and/or reported in the parent trial publication, n=16). An association was observed between the publication rates and the length of time between trial activation and closure as well as cancer type.The study was published online in the journal <a href="https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.32765">Cancer</a>.&ldquo;The results of the current study demonstrated that approximately 45% of the PT publications were followed by a HRQOL publication within 1 year, to allow the knowledge to be used in patient treatment decision making. The authors believe the current analysis is an important first step toward a better understand of the challenges that researchers face when reporting HRQOL endpoints,&rdquo; summarized the study authors.

Jordana Jampel

FDA Approves Novel Blood Test for Alzheimer’s Detection

Dementia

Andrew Moreno

Is Plasma Mannose-Binding Lectin a Clue to Higher VTE Risk?

Katie Kosko

EMBER-3: Imlunestrant Plus Abemaciclib Improves PFS in ER+ Breast Cancer

HR Breast Cancer

Latest News

An Assessment of Health‐related Quality of Life Endpoints Reporting in Trials Supported by the National Cancer Institute

Oncology

A study examined how publications are reporting health‐related quality of life (HRQOL) in clinical trials supported by the National Cancer Institute (NCI). ...

An Assessment of Health‐related Quality of Life Endpoints Reporting in Trials Supported by the

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe